Glucare XR is a medication classified as an extended-release formulation of metformin, a biguanide antidiabetic agent. Metformin works by decreasing glucose production in the liver and improving insulin sensitivity in peripheral tissues. This helps lower blood sugar levels in patients with type 2 diabetes. Glucare XR is indicated for the management of type 2 diabetes mellitus in adults. It is commonly prescribed to improve glycemic control and reduce the risk of complications associated with diabetes. Clinical studies have shown that Glucare XR can effectively lower hemoglobin A1c levels, improve insulin sensitivity, and aid in weight management. It is an essential component of a comprehensive treatment plan that includes diet and exercise. Glucare XR is well-tolerated by most patients and has a favorable safety profile when used as directed.